ReviewCancer reports (Hoboken, N.J.)2022

Neoadjuvant lenvatinib for inoperable thyroid cancer: A case report and literature review.

Khalid Alshehri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.